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The Combinatorial Extension Method Reveals
a Sphingolipid Binding Domain on Pancreatic
Bile Salt-Dependent Lipase: Role in Secretion
to as PEST sequences which are signal for rapid degra-
dation of proteins (Rechsteiner and Rogers, 1996). This
domain is located within the C-terminal tandemly re-
peated identical mucin-like sequences of the protein
(Reue et al., 1991). We have also demonstrated that the
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enzyme accomplishes its physiological role (Lombardo,
2001). We have further shown that BSDL that cannot be
correctly folded by Grp94 upon dissociation from theSummary
BSDL-Grp94 complex with geldanamycin was directed
to the degradation pathway implicating the proteasomeStructure similarity searches using a combinatorial ex-
(Nganga et al., 2000) and ubiquitination (Le Petit-Theve-tension appoach revealed that a protein fold structur-
nin et al., 2001b). Polyunsaturated fatty acid incorpora-ally related to the sphingolipid binding domain (SBD)
tion into lipid membranes of pancreatic cells, lowers theof HIV-1 gp120 (V3 loop) is present on pancreatic bile
BSDL secretion rate, and increases both retention insalt-dependent lipase (BSDL). A synthetic peptide de-
microsomes and degradation of the enzyme (Le Petit-rived from the predicted V3-like domain of BSDL inter-
Thevenin et al., 2001a). Furthermore, a fraction of BSDLacted with reconstituted monolayers of sphingolipids
has been detected in the detergent insoluble fractionssuch as GalCer and GlcCer. Using Chinese hamster
of human and rat pancreatic microsomes (Bruneau etovary cells stably transfected with the cDNA encoding
al., 1995; Bruneau and Lombardo, 1995) which containthe rat BSDL (CHO-3B clone) or pancreatic SOJ-6 cells
raft-associated membrane proteins such as glycosyl-expressing the human BSDL as models, we showed
phosphatidyl inositol (GPI)-anchored proteins (Hooperthat the enzyme cofractionates with caveolin-1. The
and Bashir, 1991). All this suggests that BSDL couldsecretion of BSDL by CHO-3B cells was inhibited by
interact with lipid rafts microdomains during its routepermeable drugs affecting rafts structure (D609,
toward secretion.PDMP, and filipin). Data suggest that the functional
Rafts, also referred to as detergent-insoluble com-interaction between the BSDL SBD and lipid rafts is
plexes, are membrane microdomains enriched in sphin-physiologically relevant and could be essential for
golipids and cholesterol that are thought to originatesensing the BSDL folding prior to secretion. A tentative
from the Golgi apparatus. Rafts have been proposed tomodel accounting for the phosphorylation-induced
function as a sorting platform for the apical delivery ofdissociation of BSDL from rafts is presented.
plasma membrane proteins (Simons and Ikonen, 1997;
Wang et al., 2002), to play a role in signal transduction
Introduction (Horejsi et al., 1999; Langlet et al., 2000), infection (Hug
et al., 2000; Lafont, et al., 2002), and secretion (Martin-
Bile salt-dependent lipase (BSDL, E.C.3.1.1.13) is an Belmonte et al., 2000). Raft association is mediated ei-
enzyme involved in the duodenal hydrolysis of cholest- ther by the transmembrane domain (Lin et al., 1998) or
eryl esters. The enzyme is synthesized in the endoplas- by the GPI anchor (Harder and Simons, 1997) of proteins.
mic reticulum (ER) of pancreatic acinar cells, and then However, in a recent study Mahfoud et al. (2002a) have
follows the secretory pathway of these cells to be se- identified a common sphingolipid binding domain in Alz-
creted as a component of the pancreatic juice (Lom- heimer -amyloid peptide, prion protein, and gp120 HIV-1
bardo, 2001). BSDL is associated with membranes of protein. The characterization of this common sphingo-
the ER and the Golgi apparatus (Bruneau et al., 1995). lipid binding domain or SRB (Fantini, 2003) on these
This association involves a membrane folding multipro- proteins underscores the role of membrane rafts in
tein complex (Bruneau and Lombardo, 1995) in which pathogenesis (Fantini et al., 2002) as HIV exploits rafts
the Grp94 chaperone helps in the last folding steps to travel accross intestinal epithelium.
(Nganga et al., 2000) of BSDL. The association of BSDL In this study, we have shown that a (glyco)sphingolipid
with intracellular membranes could be essential for the binding domain structurally related to the V-3 loop of
complete O-glycosylation of a BSDL domain, rich in pro- the gp120 HIV-1 protein can be detected on BSDL using
line, threonine, serine, and glutamic acid, and referred incremental combinatorial extention method (Shindya-
lov and Bourne, 1998). This V-3 like domain may be
essential to the association of BSDL with raft microdo-*Correspondence: dominique.lombardo@medecine.univ-mrs.fr
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mains whose integrity is essential to BSDL secretion by the resulting interaction was measured as an increase
in the surface pressure of the film (Mahfoud et al., 2002a).pancreatic acinar cells.
A preliminary experiment demonstrated that the BSDL
synthetic peptide did not affect the surface tension ofResults
water in absence of lipid (data not shown). In contrast,
this peptide interacted specifically with GalCer and theCharacterization of a V3-like Domain on BSDL
interaction was dose dependent (Figure 2A). The maxi-One hallmark of the human immunodeficiency virus
mal increase in surface pressure ( max  20 mM/m)(HIV)-1 binding to cell surface during infection is a spe-
was obtained for a peptide concentration of 400 nM,cific interaction with glycosphingolipids (GalCer, globo-
with a half-maximal effect at 50 nM. Overall, data ob-triaosylceramide) present in lipid rafts (Guex and
tained with the BSDL synthetic peptide were consistentPeitsch, 1997; Fantini et al., 2000; Mahfoud et al., 2002b;
with those previously obtained with synthetic peptidesHug et al., 2000). This binding is mediated by the V3
derived from the gp120 V3 loop, the Alzheimer-amyloidloop of the surface envelope glycoprotein gp 120 (Guex
peptide, and the cellular prion protein (Mahfoud et al.,and Peitsch, 1997). In solution the V3 loop adopts a
2002a).typical hairpin fold, which has been also characterized
To assess the specificity of the interaction with sphin-in amyloid proteins (Fantini et al., 2002; Mahfoud et al.,
golipids of the BSDL synthetic peptide, monomolecular2002a). The possible association of BSDL with rafts in
films of GalCer were prepared at various initial pressurespancreatic microsomes (Bruneau et al., 1995; Bruneau
(i), and the maximal increase in surface pressure (and Lombardo, 1995) led us to investigate whether such
max) induced by the synthetic peptide on these filmsa V3-like structural consensus domain is present on
was determined after equilibrium has been reached. AsBSDL. For this purpose structure similarity searches
shown in Figure 2B,  max gradually decreasedwere performed using the combinatorial extension
whereas i increased. The critical pressure of insertionmethod (CE) (Shindyalov and Bourne, 1998) and a struc-
(i.e., the theoretical value ofi extrapolated formaxtural alignment of BSDL and the V3 loop motif of the
0 mN/m) was 45 mN/m. This value is greater than thegp120 protein has be obtained (Figures 1A and 1B). The
mean density of lipids in cell membranes, which hasV3-like domain of BSDL is comprised between residues
been estimated around 30 mN/m (Larson and Quinn,Asp361 and Leu393. This motif is a hairpin structure
1994). A specific interaction was also observed withconsisting of a helix-turn-helix motif formed by the end
GlcCer. In this case, below 25 mN/m, a i value corre-of helix J (amino acids 355–368), followed by the -turn sponding to a fluid disordered (Lc) phase, the  max(amino acids 369–376), and the beginning of helix K induced by the BSDL synthetic peptide, was between(amino acids 377–407) of the BSDL structure (Wang et
5 and 10 mN/m (Figure 2C). At a i of 25 mN/m, theal., 1997). The HIV-1 V3 loop motif contains aromatic
value of  max reached 20 mN/m, then for values ofresidues that mediate binding to individual sugar rings
i above 25 mN/m, a pressure which does correspondof glycosphingolipids (Fantini et al., 2002; Mahfoud et
to liquid-ordered (Lo) phase domains, max graduallyal., 2002b). Interestingly, there is also an aromatic resi-
decreased as i increased and reached a critical pres-due (i.e., Trp371) in the BSDL motif that could be essen-
sure of insertion at approximately 46 mN/m. From thesetial for sphingolipid binding. This residue is found in a
data, one could conclude that the interaction of thesymetrical position with regard to residues Phe20 or
BSDL synthetic peptide with GalCer and GlcCer is opti-Tyr21 of the gp120 V3 loop (Figure 1B). This loop is
mal when glycosphingolipids form a densely packedexposed to the solvent and fully accessible on the sur-
monolayer, a molecular organization likely preponderantface of BSDL, consistent with a potential role in sphin-
in the liquid-ordered phase of lipid rafts (Brown, 1998).golipid binding (Figure 1C). Finally, alignment parame-
Contrary to previously characterized V3-like domainsters provided by the CE program suggest that the
(Mahfoud et al., 2002a), the synthetic peptide of BSDLstructural similarity between the gp120 V3 loop and the
did not bind specifically to sphingomyelin (Figure 2B).sequence 361–393 of BSDL is highly significant (Table 1).
Indeed, the peptide did not increase the pressure of aIn particular, the root-mean-square-deviation was 4 A˚
sphingomyelin film above a i of 25 mN/m. This resultand the statistical significance of the alignment (Z-score)
is not surprising if one considers that in the Glu200 Lyswas 3.
mutant of the prion protein, the resulting redistribution
of surface charges dramatically affected binding to
The V3-like Domain of BSDL Is a Sphingolipid sphingomyelin but had no effect on GalCer recognition
Binding Domain (Mahfoud et al., 2002a). Examining the V3-like loop de-
The identification of a V3-like domain on BSDL prompted rived from the BSDL sequence suggests that its struc-
us to study the interaction of this domain with glyco- ture in aqueous solution could be stabilized by saline
sphingolipids (GalCer and GlcCer) and sphingomyelin. bridges between Arg380 and Asp374, and between
A peptide derived from the bovine BSDL sequence from Lys382 and Glu377 (Figure 3). Accordingly, these
Asp361 to Leu393 (NATYEVYTEPWAQDSSQTETRKKT charged residues are no more susceptible to interact
MVDLETDIL) was synthesized and its interaction with with the charged polar head group of sphingomyelin.
sphingolipids was analyzed using the Langmuir film bal-
ance as previously described (Mahfoud et al., 2002a). BSDL Cofractionates with Caveolin-1
In these experiments, the synthetic peptide was added of Raft Microdomains
to the aqueous subphase underneath the monomolecu- It is now clearly established that (glyco)sphingolipids
are essential constituents for the formation of rafts (Si-lar film formed by lipids at the water-air interface, and
Lipid Rafts in BSDL Secretion
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Figure 1. Structural Homology between HIV-I
gp120 and BSDL
(A) Structure-based sequence alignment of
HIV-I gp120 (V3 loop) and BSDL (sequence
361–393). For each sequence, PDB entry
name as well as starting and ending residues
are given. Alignment parameters are given in
Table 1.
(B) Superimposition of the sphingolipid bind-
ing motif in the V3 loop of HIV-I gp120 (red)
and BSDL (blue). The lateral chains of the
aromatic residues potentially involved in
binding to glycosphingolipid are shown;
BSDL Trp371 in yellow, V3 loop Tyr21 in
green.
(C) Location of the V3-like domain (blue) in
the three-dimensional structure of BSDL.
Residues Trp371 (yellow) and the phosphory-
lation site Thr340 (purple) are indicated.
mons and Ikonen, 1997; Brown and London, 2000); mulates (Bruneau and Lombardo, 1995). We also used
the CHO-K1 cells transfected with the cDNA of the rattherefore, we have investigated whether BSDL can asso-
ciate with lipids rafts as suggested by the presence BSDL referred to as the CHO-3B clone (Bruneau et al.,
1997). Rat BSDL which locates with Rab5 within solublesof the V3-like domain on BSDL and by previous data
(Bruneau et al., 1995; Bruneau and Lombardo, 1995). fractions 8 and 9, can also be detected in fractions 2–5
which are enriched in caveolin-1 (Figure 4B). Conse-For this purpose, we have isolated raft microdomains
from the human pancreatic SOJ-6 cells using a step quently, in CHO-3B cells expressing and secreting re-
combinant rat BSDL (Bruneau et al., 1997), as well assucrose gradient. Gradient fractions were examined by
SDS-PAGE and Western blot using antibodies to caveo- in pancreatic SOJ-6 cells which constitutively expressed
human BSDL (Pasqualini et al., 1998), a fraction of thelin-1 to locate raft microdomains (Schubert et al., 2002)
and pAbL64 to detect the human BSDL. As shown in enzyme cofractionates with caveolin-1 and likely colo-
cates with raft microdomains.Figure 4A, caveolin-1 colocates with BSDL within frac-
tions 2–5, whereas Rab5, a cytosolic protein associated Another possibility is that secreted BSDL, by means
of the V3-like domain, can be recaptured after its associ-with endosomes trafficking is mainly associated with
soluble fractions 8 and 9. Of course, BSDL is also pres- ation with rafts microdomains of the acinar cell plasma
membrane. To answer this specific point, we have per-ent in soluble fractions as the result of detergent lysis
of secretory vesicles where mature soluble BSDL accu- formed a biotinylation of SOJ-6 cell surface proteins.
Structure
1440
Table 1. Structure-Based Alignment Parameters Obtained with
the CE Program
CE Parameter a 1AKN versus 1CE4
Rmsd (A˚ )b 3.7
Z-scorec 3.1
Sequence identity (%) 0
Aligned/gap positions d 32/0
The proteins are identified with their PDB entry numbers: 1CE4,
HIV-I gp120 V3 loop; 1AKN, BSDL.
a Provided by the CE program using the two chains alignment routine
(the resulting alignments are shown in Figure 1). Structure similarity
searches were performed with default parameter, except for the
“select similarity level” option (“high” instead of “medium” in order
to obtain a close match).
b Root-mean-square deviation, rmsd (should be5 A˚ since members
of the same protein family that obviously have the same fold can
differ by up to 4 A˚ or more in rmsd).
c Measure of statistical significance of the result relative to an align-
ment of random structures (range 2.5–5.0). The Z-score is generally
used to filter less significant results or alternatively look for weak
similarities. The relatively low values of the Z-score (i.e., 3.5) may
be explained by the absence of sequence identity between the
aligned motifs.
d Ideally, the number of gap positions in alignment between two
chains should be less than 20% of aligned residue positions.
For this purpose, SOJ-6 cells were grown until conflu-
ence, then cell surface proteins were biotinylated, and
cells were washed and lysed. The material was loaded
on streptavidin-agarose beads and the biotinylated ma-
terial eluted by acetic acid was further separated on
SDS-PAGE and electrotransferred onto nitrocellulose
membranes. The membranes were finally probed with
antibodies to biotin and to BSDL (Figure 5). Results
showed that many proteins were reactive with antibod-
ies to biotin (lane 1, 0.5 g of biotinylated proteins);
however, except for a 32 kDa peptide, no material asso-
ciated with the size of human BSDL (i.e., 120 kDa)
was probed with pAbL64 (lane 2, 5 g of biotinylated
proteins). For comparison, lane 3 displays the migration
of mature BSDL from SOJ-6 cell culture medium. This
result suggests that BSDL does not associate with rafts
at the level of the cell plasma membrane. Therefore
BSDL associates with intracellular raft microdomains,
and this binding likely involves the V3-like domain of the
enzyme and the (glyco)sphingolipids of rafts.
Disorganization of Membrane Raft Structure
Figure 2. Binding of the BSDL-Derived Synthetic Peptide to Mono-Decreases the Secretion Rate of BSDL
molecular Film of GlycosphingolipidsSince the sequence of the BSDL synthetic peptide corre-
(A) Dose-dependent interaction between the BSDL-derived syn-sponds to a loop located at the surface of the enzyme
thetic peptide and monomolecular film of GalCer prepared at an(Figure 1C) and since pancreatic BSDL associates with
initial pressure (i) of 10 mN/m. Increases in the surface pressurerafts (Figure 4), we wondered what could be the physio-
induced by the synthetic peptide added to the aqueous subphase
logical relevance of this glycosphingolipid binding do- at the concentration as indicated, were determined at equilibrium.
main in BSDL secretion. Pharmacological manipulation (B and C) Maximal surface increase (max) reached after injection
of membrane lipid levels with well-documented drugs of BSDL synthetic peptide under GalCer (circles) and sphingomyelin
(triangles) (Figure 2B) or GlcCer (squares) (Figure 2C) films at varioushas been used to address the role of lipid rafts in many
initial surface pressures (i). The synthetic peptide was used at asystems. For this purpose we have used methyl-
final concentration of 0.5 M. Results are means 	 SD of three-cyclodextrin a drug described to deplete cholesterol
independent experiments and invisible error bars are within symbol
in membrane rafts (Chen and Resh, 2002). At drug con- size.
centrations devoid of cytotoxicity, methyl--cyclodex-
trin had no effect on BSDL secretion by CHO-3B cells
(Figure 6A). In contrast, the sequestration of cholesterol
Lipid Rafts in BSDL Secretion
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Figure 4. Localization of BSDL in Caveolin-1-Rich Membrane
Fraction
(A) SOJ-6 human pancreatic cells were treated with Brij98 to isolate
raft microdomains which were monitored by the distribution of ca-
veolin-1 over the step sucrose gradient. Fractions of the sucrose
gradient (30 l) were analyzed by SDS-PAGE and electrotransferred
onto nitrocellulose membranes. These membranes were probed
with antibodies to caveolin-1 (Cav-1), with pAbL64 against human
BSDL (BSDL), or with antibodies to Rab5 (Rab5).
(B) CHO cells expressing the rat BSDL (CHO-3B clone) were treated
and analyzed as in (A), excepted that the rat BSDL was probed with
the pAbL10.
As shown in Figure 7A, D609 totally inhibited the secre-
tion of BSDL by CHO-3B cells. Because D609 also par-
tially inhibited the BSDL activity, we have checked by
Western blot using pAbL10 that the protein is actually
absent from the cell culture medium upon treatment ofFigure 3. Modeling of the Synthetic Peptide Structure Derived from
CHO-3B cells with the drug. As shown in Figure 7B inthe Bovine BSDL
the absence of D609, BSDL can be detected in the cell(A) Sequence alignments showing that many charged residues are
culture medium after 4 hr incubation, and then the se-conserved in bovine (BOVBSDL), human (HUMBSDL), ferret
(FERBSDL), mouse (MOUBSDL), and rat (RATBSDL) corresponding creted amount of BSDL increases with time, whereas
sequences (Sbarra et al., 1998). Asterisks indicate matches, double no BSDL protein can be detected in the culture medium
dots indicate conserved residues, and single dots indicate mis- of D609-treated CHO-3B cells. In addition, the depletion
matches.
of glycosphingolipids in rafts of CHO-3B cells with(B) The model based on the three-dimensional structure of BSDL
PDMP significantly slowed the secretion rate of BSDLshows potential saline interactions (between Arg380 and Asp374,
(Figure 7C). This result suggests that BSDL exploits (glyco)and between Lys382 and Glu378) in the BSDL synthetic peptide.
sphingolipids of lipid rafts during its secretion process.
Cells in culture are estimated to internalize via endo-
cytosis about half their plasma membrane per hour(Chen and Resh, 2002) by filipin (Figure 6B) induced a
dramatic decrease in the secretion rate of BSDL. (Steinman et al., 1983). This event is followed by a paral-
lel process of recycling, remodeling, and resynthesisSphingolipids also participates in raft structure; there-
fore, we used metabolic inhibitors of (glyco)sphingolipid of membrane components, in part lipids, in order to
maintain the cell surface composition as dynamicallybiosynthesis. In the first instance we have used inhibitors
acting early in sphingolipid synthesis such as L-cyclo- constant. Therefore, the fact that early inhibitors of
sphingolipid synthesis are uneffective in decreasing theserine (an inhibitor of serine palmitoyltransferase) and
Fumonisin 1 or 2 (both inhibitors of dihydroceramide secretion rate of BSDL suggests that the salvage path-
way recycling surface glycosphingolipids (Tettamanti etsynthetase). Although used at efficace concentration (10
and 20 M for L-cycloserine and Fumonisin, respec- al., 2003) is sufficient to insure the formation of lipid
rafts in CHO-3B cells and able to drive BSDL towardtively) none of these inhibitors interferes with the secre-
tion of BSDL by CHO-3B cells (data not shown). We secretion. This salvage pathway in part connects lyso-
somes to the Golgi apparatus (Chen et al., 1998); conse-therefore turned to inhibitors acting later in sphingolipid
synthesis such as D609 (partly an inhibitor of sphingo- quently, the lysosomal hydrolase inhibitor chloroquine
causes the arrest of the metabolic salvage pathway (Tet-myelin synthesis) and PDMP (an inhibitor of glycosphin-
golipid synthesis) to alter membrane rafts composition tamanti et al., 2003). As shown in Figure 8, incubation
of CHO-3B cells with chloroquine (1 mg/ml) caused aand to disturb their structure (Lefrancois et al., 2002).
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Figure 5. Immunodetection of Biotinylated Cell Surface Proteins in
SOJ-6 Cells Lysate
SOJ-6 cells were grown until confluence, and membrane proteins
were biotinylated, and finally cells were lysed. Then biotinylated
membrane proteins were purified on a streptavidin-agarose affinity
column. The material eluted with 0.1 M acetic acid was separated
on SDS-PAGE, electrotransferred onto nitrocellulose membranes,
and probed with anti-biotin antibodies (lane 1, 0.5 g of biotinylated
proteins) and pAbL64 (lane 2, 5 g of biotinylated proteins). Lane 3
displays an immunodetection experiment using pAbL64 on secreted
material (i.e., material associated with the SOJ-6 cells culture me-
dium). Arrow indicates the apparent molecular mass of detected
proteins.
significant inhibition of BSDL secretion. These data sug-
gested that (i) the salvage pathway recycling membrane
lipids between lysosomes and the Golgi apparatus is
active in CHO-3B cells, (ii) this pathway is large enough
to assume the formation of lipid rafts in these cells and Figure 6. Effect of Drugs Affecting Cholesterol on BSDL Secretion
the resulting secretion of BSDL, and (iii) BSDL associ- CHO-3B cells secreting the rat BSDL were cultured in Ham’s F12
ates with lipid rafts in the Golgi apparatus. medium until 80% confluence. At time zero the culture medium was
replaced by fresh medium containing methyl--cyclodextrin (20 mM,
[A]) or filipin (1 M, [B]). Aliquots of the culture medium were col-Discussion
lected after each time period of incubation as indicated and the
BSDL activity was recorded. Results are means	 SD of three deter-
In the present study, we have identified a specific sphin- minations. The cytotoxicity of these drugs at each incubation time
golipid binding domain in BSDL. This peptide domain period was 10% that induced by Triton X-100 (2% in cell culture
has sequence identity neither with the HIV-V3 loop pep- medium). Triangles, methyl--cyclodextrin; squares, filipin; circles,
control.tide nor with the prion peptide or with the Alzheimer
-amyloid peptide (Mahfoud et al., 2002a). However, all
these peptides present a similar structure consisting of
a helix-turn-helix motif. For BSDL, this motif is consti- continued this study and showed that BSDL cofractio-
nates with caveolin-1, taken as raft domain marker, intuted by the helix J and helix K and the domain in
between. Crystallography studies showed that this do- a step sucrose gradient following lysis of the human
pancreatic SOJ-6 cells expressing an oncofetal variantmain is located at the surface of the protein (Wang et
al., 1997). We have also demonstrated that the V3-like of BSDL (Pasqualini et al., 1998) and of the CHO-3B
cells, obtained after transfection of CHO-K1 cells withmotif of BSDL interacted with reconstituted raft-like
monolayers of GalCer and GlcCer, but not with sphingo- the cDNA of rat BSDL (Bruneau et al., 1997). These data
suggested that BSDL associates with lipid rafts in thesemyelin. In the latter case, it can be reasonably argued
that electrostatic interactions between basic and acid two cell models. This result is substantiated by the pres-
ence of a fraction of BSDL in the detergent-insolubleresidues could stabilize the structure of the synthetic
BSDL peptide in solution and consequently impair its phase fraction of human (Bruneau et al., 1995) and rat
(Bruneau and Lombardo, 1995) pancreatic cell micro-binding to the polar head group of sphingomyelin. How-
ever, in native BSDL the charged amino acids of the V3- somes or in rat pancreatic zymogen granules (Withiam-
Leitch et al., 1995) which contain GPI-anchored proteinslike domain may be bridged to residues located else-
where in the BSDL structure. Alternatively, one cannot associated with lipid rafts (Hooper and Bashir, 1991).
Sequence analyses suggested that this domain mightexclude that residues outside the V3-like domain, char-
acterized in the present study, could mediate the binding be present on BSDL independently of species origin. We
continue this study by determining the effect of drugsof BSDL to sphingomyelin.
The structure and the binding of the synthetic peptide described to affect raft integrity on BSDL secretion. Be-
cause SOJ-6 cells expressed (Pasqualini et al. 1998) butderived from BSDL to glycosphingolipids could be fortu-
itous and without physiological relevance. Therefore, we poorly secreted BSDL (Caillol et al., 2000), we used the
Lipid Rafts in BSDL Secretion
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Figure 8. Effect of Chloroquine on BSDL Secretion
CHO-3B cells were cultured to confluence. At time zero of incubation
the cell culture medium was replaced with fresh medium containing
chloroquine (1 mg/ml, closed triangles), and aliquots of the culture
medium were withdrawn after time periods of incubation as indi-
cated, and finally the BSDL activity was recorded. A control experi-
ment was performed in the absence of chloroquine (circles). The
cytotoxicity of this drug at each incubation time period never
reached 15% of the Triton X-100 (2%)-treated cells. Each value is
mean 	 SD from four independent experiments.
CHO-3B clone as a secretory cell model of rat BSDL.
First, we showed that cholesterol sequestration by filipin
impaired BSDL secretion, whereas cholesterol depletion
by methyl--cyclodextrin had no effect at concentra-
tions below cytotoxicity. It may be difficult to conceive
that the way of cholesterol removal, e.g., depletion ver-
sus sequestration, could differently affect BSDL secre-
tion. A simple explanation to this apparent discrepancy
is that methyl--cyclodextrin is impermeable (Awasthi-
Kalia et al., 2001) and is only able to affect the structure
of raft microdomains located at the plasma membrane
of cells, and we have seen that BSDL may not be associ-
ated with cell surface rafts. Consequently, and as al-
ready observed with the surface sorting of the GPI-
anchored placental alkaline phosphatase (Lipardi et al.,
2000), cholesterol removal from the cell surface did not
affect the exocytosis of BSDL. Another way to disrupt
lipid rafts was to inhibit the biosynthesis of (glyco)sphin-
golipids, which are major components of microdomains,
with D609 or PDMP. As expected, these inhibitors de-
creased the secretion rate of BSDL, confirming that the
disorganization of lipid rafts largely affected the secre-
Figure 7. Effect of Drugs Affecting Sphingolipids on BSDL Secretion tion process of BSDL. Therefore, one has to conclude
CHO-3B cells were cultured as described above in the legend to that the V3-like loop of BSDL is a sphingolipid binding
Figure 6. At time zero of incubation, the cell culture medium was
domain, or SBD (Fantini, 2003), that is involved in BSDLreplaced with fresh medium containing D609 (375 M, [A]) or PDMP
binding to rafts and in secretion.(60 M, [C]), aliquots of the culture medium were withdrawn after
The question now is when does the BSDL SBD be-the time period of incubation as indicated, and the BSDL activity
was recorded. Results are means 	 SD of three determinations. come functional and bind to lipid rafts. An informative
The cytotoxicity of these drugs at each incubation time period never point that could be linked to the CHO-3B cell model used
reached 15% of that promoted by Triton X-100 (2%) in cell culture in this study is that chloroquine, a lysosome hydrolase
experiments (triangles, D609; squares, PDMP; circles, control). Fig-
inhibitor, decreases the secretion rate of BSDL, whereasure 7B displays a typical immunodetection experiment performed
loading cells with GlcCer or sphingomyelin enhanceson cell culture medium samples (50 l) taken at the time indicated,
the enzyme secretion (data not shown). This suggestsof CHO-3B cells either treated (
) or untreated () with D609 (375
M). Quantification of Western blots was performed using the NIH- that the salvage processes of membrane lipids control-
Image program at http://rsb.info.nih.gov/nih-image/. ling the active concentration of ceramides and sphingo-
lipids is important enough in CHO-3B cells to assume
the formation of raft microdomains that BSDL associ-
Structure
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ates with. This salvage pathway that covers up to 90% of
total glycosphingolipid metabolism in human fibroblast
(Tettamanti et al., 2003) connects lysosomes to the Golgi
apparatus. Furthermore, in SOJ-6 cells the raft-associ-
ated fraction of BSDL was reactive with the mAbJ28
(data not shown) which recognizes terminal fucose
linked to glycans of the protein in the trans-Golgi com-
partment (Panicot et al., 1999; Colley, 1997). We have
already shown that BSDL is released from intracellular
membranes once N- and O-glycosylation were com-
pleted (Abouakil et al., 1993; Bruneau et al., 1997) in a
genistein-sensitive compartment, likely the trans-Golgi
network (Pasqualini et al., 2000), upon phosphorylation
of residue Thr340 by a casein kinase II (Ve´rine et al.,
2001; Pasqualini et al., 2000). Then, BSDL is mainly asso-
ciated with the soluble protein fraction in zymogen gran-
ules (Bruneau et al., 1995). Therefore, phosphorylation
on Thr340 may be the trans-Golgi network event that
induces BSDL release from lipid rafts. Taken as one,
these results indicate that BSDL is transiently associ-
ated with rafts from the Golgi compartment up to the
trans-Golgi network.
From this point, another important issue is to explain
how BSDL is released from lipid rafts to be secreted.
Thr 340 residue locates at the end of the helix I which is
parallel to helix K (Wang et al., 1997). As a consequence,
Thr340 is in a vis-a`-vis position of a polar residue Gln377
of the BSDL SBD (Figures 9A and 9B). Therefore the
bulky and negatively charged phosphoryl group of the
phosphorylated Thr 340 could perturbate the helix I
structure via a repulsive effect on negatively charged
Glu341, Glu342, and Asp343 residues and via an attrac-
tive effect on positive Gln377 residue of the helix K.
This may generate a conformational change in the V3-
like loop structure that in turn may lead to dissociation.
Clearly the simple switch of charge at position Glu200
into Lys200 profoundly modifies the binding to sphingo-
lipids of the V3-like peptide derived from the mutant of
the prion protein associated with the Creutzfeldt-Jakob
disease (Mahfoud et al., 2002a). The possible conforma-
tional change occurring during the release process is
enlighted by the lack in activity of the membrane-associ-
ated BSDL that gains full activity once released from
membranes (Bruneau et al., 1995; Bruneau and Lom-
bardo, 1995). Interestingly, it has been shown that the
sequence 490–534 of BSDL is required for normal intra-
cellular processing and secretion of the enzyme (DiPer-
sio et al., 1994). The ribbon model (Figure 9C) indicates
that this domain is close to the BSDL SBD. Once deleted,
this sequence 490–534 (which presents homologies be-
tween species, Figure 9D) induced the retention of the
unproperly folded and inactive enzyme in membraneFigure 9. Hypothesis on Threonine 340 Phosphorylation and BSDL
microsome fraction (DiPersio et al., 1994). Therefore,Release from Rafts
unfolded BSDL is associated with the membrane, and(A) The ribbon model shows that the phosphorylatable Thr340 resi-
it has been shown that Grp94 is involved in this associa-due of helix I is proximal to the Gln377 residue of the V3-like loop
of BSDL and the helix I. The phosphorylation of Thr340 could result
in structural modifications of the helix I via electrostatic repulsion
of negatively charged Glu341, Glu342, and Asp343 residues and
attraction of the helix K Gln377 residue. Finally, this could lead to conserved residues.
the release of BSDL from membranes and secretion. (C) The ribbon model displays the sequence 490–534 (red) involved
(B) The sequence following the Thr340 residue is perfectly con- in the proper folding of BSDL (DiPersio et al., 1994). The V3-like
served in bovine (BOVBSDL), human (HUMBSDL), ferret (FERBSDL), loop is in blue.
mouse (MOUBSDL), and rat (RATBSDL) corresponding sequences (D) Sequence homologies between residues 490 and 534 of BSDL
(Sbarra et al., 1998). Asterisks indicate matches and double dots (see [B] for legend).
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the equilibrium was reached (maximal surface pressure increase tion (Bruneau et al., 1997). All these results suggest
max) as indicated elsewhere (Hammache et al., 1998). The datathat Grp94 achieves the folding of BSDL, and that only
were analyzed with the Filmware 2.3 program (Kibron Inc.).properly folded BSDL may be completely glycosylated
(Bruneau and Lombardo, 1995), in part O-glycosylated SOJ-6 Cell Culture
at the level of the C-terminal domain of BSDL (Wang et Human pancreatic SOJ-6 cells expressing an oncofetal variant of
al., 1995). Only BSDL molecules that have completed BSDL were kindly provided by Dr. M.-J. Escribano (INSERM, Mar-
seille) and cultured as previously described (Pasqualini et al., 1998).these steps are able to associate with lipid rafts. Thus,
the correct folding of the SBD of BSDL may determine
CHO-K1 Cell Culture and Incubation with Drugsthe right conformation of the whole BSDL molecule.
CHO-K1 cells transfected with the full-length cDNA encoding the
Therefore, only correctly folded BSDL molecules could rat BSDL and referred to as the CHO-3B clone were cultured as
be susceptible to bind to rafts (or related structures) already described (Bruneau et al., 1997). Cells were grown in 3 cm
and to become accessible to phosphorylation on Thr340 diameter Petri plates until 80% confluence was reached, then at
time zero of incubation the cell culture medium was replaced byby a casein kinase (Pasqualini et al., 1997) and further
fresh medium containing effectors at a final concentration as men-secreted.
tioned. Control experiments were performed in the absence of drug.In conclusion, our study underscores the capacity of
the incremental combinatorial extension method devel-
Biotinylation and Streptavidin Precipitation
oped by Shindyalov and Bourne (1998) to identify struc- of Cell Surface Proteins
turally related domains sharing common functional SOJ-6 cells were washed three times with PBS; they were then
released from culture plates by treatment with a nonenzymatic cell-properties in proteins without sequence identity (Mah-
dissociation solution (Sigma) for 15 min at 37C. The cells werefoud et al., 2002a). In this respect the characterization
suspended at a concentration of 25  106 cells/ml in ice-cold PBSof a structurally conserved sphingolipid binding domain
(pH 8.0) and 0.5 mg of sulfo-NHS-LC biotin (PerbioScience, Helsi-potentially involved in the binding to lipid raft compo-
borg, Sweden) was added per milliliter of reaction volume including
nents may be a typical example of such functional iden- Complete EDTA-free mix (Roche Diagnostic) to avoid degradation
tity that is independent of sequence homology (Fantini, of proteins. The mixture was incubated at 4C for 2–3 hr. The cells
were washed then three times with ice-cold PBS (pH 8.0) to remove2003). A functional sphingolipid binding domain struc-
the remaining biotinylation reagent. After centrifugation, the cellturally related to the V3 loop of HIV-1 gp120 has already
pellet was resuspended in an adequate volume of ice-cold PBS,been delineated in prion and Alzheimer proteins (Mah-
sonicated 15 s twice, and cleared by centrifugation (30 min. 4C,foud et al., 2002a). Results of the present study further
13,000  g). The supernatant, containing biotinylated cell surface
show that a similar domain can be found in cellular proteins (300 g), was loaded on streptavidin-agarose beads (150
proteins such as BSDL, which associates with rafts dur- l, Sigma) and incubated overnight at 4C under agitation. The beads
were exhaustively washed with PBS; then complexes formed ofing secretory processes. From these data, one can an-
biotinylated proteins bound to streptavidin-agarose beads were dis-ticipate that the presence of a surface-exposed SBD as
sociated by 0.1 M acetic acid (pH 2.0) for 30 min at 37C, anddetected by the incremental CE program on proteins of
centrifuged to collect the supernatant where locate biotinylated pro-known structure may support binding to lipid rafts (or
teins. Biotinylated material was separated on SDS-PAGE, electro-
to related structures). transferred onto nitrocellulose membranes, and probed with ade-
quate antibodies.
Experimental Procedures
Enzyme Assays and Protein Determination
Materials BSDL activity was recorded using 4-nitrophenyl hexanoate (Gjelles-
The chemicals used in this study including GlcCer, GalCer, sphingo- vik et al., 1994). Except for D609 that decreased by some 30%–40%
myelin, PDMP, methyl -cyclodextrin, filipin, Brij98, Triton X-100, the BSDL activity, drugs used under the conditions of this study did
D609, and alkaline phosphatase-labeled antibodies to rabbit and affect the enzyme activity or were cytotoxic. Protein concentrations
mouse immunoglobulins were from Sigma. The synthetic peptide were determined using the microBCA kit (Pierce).
derived from the bovine BSDL sequence was purchased from Q-Bio-
gene (Evry, France). The peptide was purified by high-performance Raft Isolation
liquid chromatography (purity 95%) and characterized by mass Raft microdomains were isolated according to Drevot et al. (2002).
spectrometry (experimental Mr of 3761.99, theoretical Mr of 3763.1). Briefly, SOJ-6 or CHO-3B cells (2  108) were suspended in 1 ml of
Polyclonal antibodies to human BSDL (pAbL64) and to rat BSDL buffer A (25 mM HEPES, 150 mM NaCl, 1 mM EGTA, 5 mM Na3VO4,
(pAbL10) were homemade (Bruneau et al., 1995; Aubert et al., 2002), 10 mM NaPP, 10 mM NaF, and protease inhibitors) and homoge-
and polyclonal antibodies to caveolin-1 were from Santa Cruz Bio- nized by sonication (5 5 s, 4 w, 4C, Branson sonifier). The postnu-
technology (Santa Cruz, CA). clear supernatant obtained by centrifugation of the homogenate
(1260 g, 10 min, 4C) was then incubated at 37C (to avoid unspe-
Structure Analysis cific binding to rafts) in the presence of Brij 98 (1% final concentra-
Structure similarity analyses were performed using the two chains tion). After 5 min solubilization, the homogenate was diluted with
calculation routine of the CE combinatorial extension program (Shin- 2 ml of buffer A containing 2 M sucrose (final sucrose concentration
dyalov and Bourne, 1998), as previously described (Mahfoud et al., 1.33 M; final Brij 98 concentration 0.33%) and chilled down on ice
2002a). Briefly, the CE program aligns two polypeptide chains using (55 min) before being placed at the bottom of a step sucrose gradient
characteristics of their local geometry as defined by vectors be- (0.9-0.8-0.75-0.7-0.6-0.5-0.4-0.2 M sucrose, 1 ml each) in buffer A.
tween carbon  positions. Molecular structures were visualized us- The gradient was centrifuged at 38,000 rpm for 21 hr using a SW41
ing the Swiss-PDB viewer (Guex and Peitsch, 1997). PDB identifica- rotor (Beckman Instruments Inc.) at 4C. One milliliter fractions were
tion numbers were 1CE4 for HIV-1 gp120 and 1AKN for BSDL, collected from top to bottom, except for the last fraction (fraction
respectively. Nb. 9), which contains three milliliter. Fractions were further resus-
pended in the Laemmli’s loading buffer (1970).
Surface Pressure Measurements
The surface pressure was measured with a fully automated micro- SDS-PAGE and Western Blot
SDS-PAGE was performed on 7.5% polyacrylamide and 0.1% SDStensiometer (TROUGH SX-Kibron Inc.) as already described (Mah-
foud et al., 2002a). Pressure increases were recorded at 20C until slab gels as described by Laemmli (1970) using a BioRad Mini Pro-
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tean II apparatus (Richmond, WI). After electrophoretic migration, Colley, K.J. (1997). Golgi localization of glycosyltransferases: more
questions than answers. Glycobiology 7, 1–13.proteins were electrotransferred onto nitrocellulose membranes at
4 mA/cm2 for 18 hr. The efficiency of electrotransfer was checked by DiPersio, L., Carter, C., and Hui, D.Y. (1994). Exon 11 of the rat
staining the nitrocellulose membrane with 2% Ponceau S solution. cholesterol esterase gene encodes domains important for intracellu-
Nitrocellulose membranes were air-dried, and the transferred pro- lar processing and bile salt-modulated activity of the protein. Bio-
teins were immunodetected using adequate primary and secondary chemistry 33, 3442–3448.
antibodies. Membranes were developed for 10 min with a mixture Drevot, P., Langlet, C., Guo, X.-J., Bernard, A.-M., Colard, O., Chau-
of nitro-blue tetrazolium and 5-bromo-4-chloro-3-indoyl phosphate vin, J.-P., Lasserre, R., and He, H.-T. (2002). TCR signal initiation
(0.5 mM each) in 0.1 M Tris/HCl buffer (pH 9.5), 100 mM NaCl, and machinery is pre-assembled and activated in a subset of membrane
1 mM MgCl2. rafts. EMBO J. 21, 1899–1908.
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